Related Experiment Video

Updated: Jul 24, 2026

Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring
08:45

Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring

Published on: November 13, 2012

The value of CEA measurement in clinical practice

J P Persijn

    Annals of Clinical Biochemistry
    |July 1, 1985
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Quantification of Coenzyme A in Cells and Tissues08:51

    Quantification of Coenzyme A in Cells and Tissues

    Published on: September 27, 2019

    Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets11:03

    Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

    Published on: February 10, 2020

    Related Concept Videos

    Methods of Documentation V: CBE01:23

    Methods of Documentation V: CBE

    Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
    In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

    Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...